GeneTex Antibody Company Announces New Exclusive Distribution Agreement with VWR International, LLC
IRVINE, Calif., Sept. 24, 2012 /PRNewswire/ — GeneTex, a leading manufacturer and supplier of antibodies and antibody-related reagents, announced an exclusive distribution agreement for North America with VWR, making GeneTex one of the premier antibody suppliers to VWR.
The extensive GeneTex product portfolio of more than 52,000 antibodies with more than 15,000 unique targets is now conveniently accessible to top pharmaceutical and biotech companies, as well as industrial, educational and governmental organizations. GeneTex products service a wide range of life science research areas including cancer research, signal transduction, stem cells and development, cell biology, epigenetics, immunology and vascular biology, infectious disease, metabolism, neuroscience, and an extensive line of zebrafish antibodies.
“We are excited and proud to have one of the leading life science companies work with GeneTex,” said Dr. James Wang, COO of GeneTex. “Having a leading company like VWR, with its long legacy of product and service excellence, join us as our exclusive North American distributor further validates the quality of GeneTex’s products.”
“We are excited about the addition of GeneTex to our extensive portfolio of antibodies,” shared Mark McLoughlin, SVP and President, U.S. Lab Solutions. “Adding GeneTex to our existing portfolio makes VWR a leading source of antibodies.”
GeneTex is an antibody company that was founded by an internationally renowned group of scientists in 1997. They strive to produce the highest quality antibodies and reagents. Their primary antibodies and secondary antibodies are created through a process involving extensive research, development and validation.